tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

OTLK Stock Latest News

OTLK Upcoming Earnings Report: What to Expect?
Pre-EarningsOTLK Upcoming Earnings Report: What to Expect?
6d ago
OTLK
Outlook Therapeutics to reduce workforce by 23%, streamline operations
PremiumThe Fly
Outlook Therapeutics to reduce workforce by 23%, streamline operations
9d ago
OTLK
Outlook Therapeutics announces NICE recommendation of LYTENAVA
PremiumThe Fly
Outlook Therapeutics announces NICE recommendation of LYTENAVA
19d ago
OTLK
Outlook Therapeutics Appoints Interim CEO After CEO Resignation
PremiumCompany Announcements
Outlook Therapeutics Appoints Interim CEO After CEO Resignation
19d ago
8K
OTLK
Outlook Therapeutics CEO Russell Trenary steps down
PremiumThe Fly
Outlook Therapeutics CEO Russell Trenary steps down
19d ago
OTLK
Outlook Therapeutics downgraded to Neutral from Buy at Chardan
PremiumThe FlyOutlook Therapeutics downgraded to Neutral from Buy at Chardan
21d ago
OTLK
Unusually active option classes on open November 29th
Premium
The Fly
Unusually active option classes on open November 29th
23d ago
K
NU
Outlook Therapeutics price target lowered to $9 from $50 at BTIG
Premium
The Fly
Outlook Therapeutics price target lowered to $9 from $50 at BTIG
24d ago
OTLK
3 Penny Stocks to Watch Now, 11/29/24
PremiumMarket News
3 Penny Stocks to Watch Now, 11/29/24
24d ago
IDAI
OTLK
Outlook Therapeutics reports preliminary results from Norse Eight trials
PremiumThe Fly
Outlook Therapeutics reports preliminary results from Norse Eight trials
26d ago
OTLK
Outlook could disrupt ocular anti-VEGF injection market, says BTIG
PremiumThe Fly
Outlook could disrupt ocular anti-VEGF injection market, says BTIG
2M ago
OTLK
JMP Securities healthcare analysts hold an analyst/industry conference call
PremiumThe Fly
JMP Securities healthcare analysts hold an analyst/industry conference call
3M ago
OPT
ABBV
Outlook Therapeutics announces completion of enrollment in NORSE EIGHT trial
PremiumThe FlyOutlook Therapeutics announces completion of enrollment in NORSE EIGHT trial
4M ago
OTLK
Outlook Therapeutics reports Q3 adjusted EPS (83c), consensus ($1.01)
Premium
The Fly
Outlook Therapeutics reports Q3 adjusted EPS (83c), consensus ($1.01)
4M ago
OTLK
OTLK Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
OTLK Earnings this Week: How Will it Perform?
4M ago
OTLK
Unity Biotechnology appoints Tozier as Chief Strategy Officer
PremiumThe Fly
Unity Biotechnology appoints Tozier as Chief Strategy Officer
5M ago
UBX
OTLK
Outlook Therapeutics announces U.K. MHRA marketing authorization for LYTENAVA
PremiumThe Fly
Outlook Therapeutics announces U.K. MHRA marketing authorization for LYTENAVA
6M ago
OTLK
Outlook Therapeutics management to meet virtually with BTIG
PremiumThe Fly
Outlook Therapeutics management to meet virtually with BTIG
6M ago
OTLK
Outlook Therapeutics receives European Commission MA for LYTENAVA
PremiumThe Fly
Outlook Therapeutics receives European Commission MA for LYTENAVA
7M ago
OTLK
Outlook Therapeutics reports Q2 EPS ($8.01) vs. (52c) last year
PremiumThe FlyOutlook Therapeutics reports Q2 EPS ($8.01) vs. (52c) last year
7M ago
OTLK
OTLK Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
OTLK Upcoming Earnings Report: What to Expect?
7M ago
OTLK
Outlook Therapeutics submits ONS-5010 MMA to MHRA for Wet AMD
Premium
The Fly
Outlook Therapeutics submits ONS-5010 MMA to MHRA for Wet AMD
7M ago
OTLK

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >